The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.
about
Assessing value of innovative molecular diagnostic tests in the concept of predictive, preventive, and personalized medicineTrends in the Application of Postmastectomy Radiotherapy for Breast Cancer With 1 to 3 Positive Axillary Nodes and Tumors ≤5 cm in the Modern Treatment Era: A Retrospective Korean Breast Cancer Society ReportTargeted adjuvant therapy in breast cancer.Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1.Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2- node positive breast cancer-A National Cancer Database study.Clinical utility of multigene profiling assays in early-stage breast cancer.Expression of oxysterol pathway genes in oestrogen-positive breast carcinomas.Can Interrogation of Tumour Characteristics Lead us to Safely Omit Adjuvant Radiotherapy in Patients with Early Breast Cancer?21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.[Determination of prognosis using gene expression analyses: Consequences for the indication for radiotherapy?].Luminal A Breast Cancer and Molecular Assays: A Review
P2860
Q26783472-D7DC251A-C9FE-40CC-8342-78A179607CAEQ36993433-3B88C007-9F04-4917-ABA3-E29BAC19D59EQ38980703-ED9CDE91-83D2-4E5A-BCFA-261B545A1C7BQ39190318-4C136967-8FCE-4A2C-87B8-9E120167A236Q42670058-09ABED99-8620-4839-943C-F343D9E4E37EQ47094168-AA89E1AB-0BAF-452B-AFB7-0FDFF2A8B4C5Q48362604-7B145B51-0B19-41EC-83D5-CF3F9645F698Q50056115-B404E3F9-57E1-4EA6-957B-E7AF20E0DF65Q51168829-6D131650-C62B-4B11-93AC-BBB137A1D05EQ55034874-65215104-6D5B-483B-AEFC-F1D12E4B521CQ57113322-FD290A42-5B86-4203-BCA0-A22500E94C6C
P2860
The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The genomic expression test En ...... the prospective ABCSG 8 trial.
@ast
The genomic expression test En ...... the prospective ABCSG 8 trial.
@en
type
label
The genomic expression test En ...... the prospective ABCSG 8 trial.
@ast
The genomic expression test En ...... the prospective ABCSG 8 trial.
@en
prefLabel
The genomic expression test En ...... the prospective ABCSG 8 trial.
@ast
The genomic expression test En ...... the prospective ABCSG 8 trial.
@en
P2093
P2860
P356
P1476
The genomic expression test En ...... the prospective ABCSG 8 trial
@en
P2093
H Samonigg
M Filipits
R Kronenwett
P2860
P2888
P304
P356
10.1038/BJC.2015.98
P407
P50
P577
2015-03-24T00:00:00Z